Science Explorer Interactive view Map
Company · Taipei · Taiwan

Efficient Pharma Management (Taiwan)

effpha.comROR OpenAlex
Research works
29
▲ 599% vs 2013–17
Citations
103
3.5 per fractional work
Top-10% rate
2.7%
record average 16.5%
Open access
17%
world 28%

Not ranked overall: Efficient Pharma Management (Taiwan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.27× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.43× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.01× its world share, 0 worksImmunology and Micro…Neuroscience: 1.60× its world share, 0 worksNeuroscienceChemistry: 1.66× its world share, 0 worksChemistryMaterials Science: 0.75× its world share, 0 worksMaterials ScienceHealth Professions: 0.49× its world share, 0 worksHealth ProfessionsMedicine: 3.41× its world share, 8 worksMedicineSocial Sciences: 0.21× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.4×. Every wedge is a field page.

Which keywords describe research at Efficient Pharma Management (Taiwan)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Breast Cancer, Chemotherapy, Fc Receptors, Therapeutic Antibodies, HER2, Trastuzumab and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Glycosylation6▲ 96×2 topics
  2. Breast Cancer6▲ 70×2 topics
  3. Chemotherapy5▲ 25×6 topics
  4. Fc Receptors5▲ 170×1 topic
  5. Therapeutic Antibodies5▲ 132×1 topic
  6. HER25▲ 534×1 topic
  7. Trastuzumab5▲ 379×1 topic
  8. Immunotherapy2▲ 13×5 topics
  9. Cancer2▲ 4.8×8 topics
  10. Tumor Microenvironment2▲ 19×7 topics
  11. Cancer Therapy2▲ 10×4 topics
  12. Inflammation2▲ 2.8×6 topics
  13. Neuroprotection2▲ 16×5 topics
  14. Tumor Regression2▲ 70×2 topics
  15. Drug Discovery2▲ 14×2 topics
  16. Metastatic Breast Cancer2▲ 88×2 topics
  17. Oxidative Stress2▲ 3.0×3 topics
  18. Tumor Targeting1▲ 35×3 topics
  19. Diabetes1▲ 8.4×2 topics
  20. PET Imaging1▲ 21×2 topics
  21. Targeted Therapy1▲ 21×3 topics
  22. Therapeutics1▲ 33×2 topics
  23. Aldose Reductase1▲ 379×1 topic
  24. Glycans1▲ 52×1 topic
  25. Immune System1▲ 13×1 topic
  26. Taurine1▲ 379×1 topic
  27. Angiogenesis1▲ 9.3×3 topics
  28. CAR T Cells1▲ 85×1 topic
  29. Cancer Immunotherapy1▲ 27×2 topics
  30. Chimeric Antigen Receptor1▲ 85×1 topic
  31. CDK4/6 Inhibitors1▲ 215×1 topic
  32. Click Chemistry1▲ 44×1 topic
  33. Copper-Catalyzed Cycloaddition1▲ 106×1 topic
  34. Palbociclib1▲ 215×1 topic

Which research topics does Efficient Pharma Management (Taiwan) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, CAR-T cell therapy research and Histone Deacetylase Inhibitors Research.

Monoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional worksHER2/EGFR in Cancer Research: 2 fractional worksCAR-T cell therapy research: 1 fractional worksHistone Deacetylase Inhibitors Research: 1 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksPeptidase Inhibition and…1Peptidase Inhibition and Analysis: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksCancer Research and Treatments: 0 fractional worksImmune Cell Function and Interaction: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyMolecular BiologyBiotechnology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 HER2/EGFR in Cancer Research Oncology 2 works
  3. 3 CAR-T cell therapy research Oncology 1 works
  4. 4 Histone Deacetylase Inhibitors Research Molecular Biology 1 works
  5. 5 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Peptidase Inhibition and Analysis Oncology 1 works
  7. 7 Cancer Treatment and Pharmacology Oncology 1 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.1%not open82.9%

World: 28% of research is openly available.

with international co-authors11.6%domestic only88.4%

World: 19% is written across borders.

How has Efficient Pharma Management (Taiwan)'s research output changed?

Output in 2018–2022 was 599% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Taipei

All research institutions in Taipei

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.